Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LLY exchanges : Nasdaq save search
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
report reach therapeutics market
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
Published: 2024-04-17 (Crawled : 20:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.81%
H: 0.0%
C: 0.0%
biotech
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
CRGX | $19.16 0.31% 0.31% 200K
|
|
| O: -1.76%
H: 6.0%
C: 2.35%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
BDTX | $5.26 -0.76% -0.76% 390K
|
Health Technology
|
| O: 0.57%
H: 2.86%
C: 2.48%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: 0.0%
H: 2.04%
C: -0.82%
therapeutics
Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published: 2024-04-11 (Crawled : 22:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -8.65%
H: 3.19%
C: 1.6%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.0%
H: 0.52%
C: -1.04%
growth market
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
drug preclinical meeting
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
Published: 2024-04-09 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -2.71%
H: 0.52%
C: 0.24%
AVTR | $24.1 -0.82% 0.25% 4.7M
|
Process Industries
|
| O: -1.7%
H: 1.08%
C: 0.55%
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: 4.99%
H: 2.78%
C: -2.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
global growth market
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
ORIC | $9.2 -3.26% -3.37% 670K
|
Health Technology
|
| O: -2.81%
H: 1.54%
C: -3.57%
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
therapeutics
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
Published: 2024-04-08 (Crawled : 22:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.02%
C: -2.62%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.06%
H: 0.22%
C: 0.0%
KNSA | $16.93 0.3% 0.3% 380K
|
Health Technology
|
| O: 0.23%
H: 1.58%
C: 0.06%
IMAB | $1.81 0.56% 0.55% 340K
|
Health Technology
|
| O: -0.55%
H: 1.39%
C: 0.0%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: 0.0%
H: 0.39%
C: -0.66%
positive growth market
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
Published: 2024-04-05 (Crawled : 12:30) - globenewswire.com
IOBT | $1.47 0.0% 92K
|
|
| O: -0.58%
H: 0.0%
C: -5.88%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -2.06%
H: 2.77%
C: 2.45%
biotech business
Blacksmith Medicines to Present at the 23rd Annual Needham Healthcare Conference
Published: 2024-04-03 (Crawled : 15:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
conference
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -2.79%
H: 1.32%
C: 1.18%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
review cancer treatment advanced china
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -2.79%
H: 1.32%
C: 1.18%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
HCM | $16.49 0.8% 0.79% 61K
|
Health Technology
|
| O: 0.21%
H: 1.49%
C: -0.06%
treatment advanced china
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
antibody research global
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
Published: 2024-03-28 (Crawled : 12:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ERAS | $1.79 0.0% 570K
|
|
| O: 17.48%
H: 6.94%
C: -14.88%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial results
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: 1.58%
H: 0.58%
C: -0.39%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.4%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 0.71%
H: 0.39%
C: 0.13%
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
|
| O: 0.39%
H: 4.22%
C: 1.41%
precision business year update financial results
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
Published: 2024-03-27 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.09%
H: 1.42%
C: 1.1%
ibi310 first cancer colon therapy study
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
MURA | $3.55 -0.56% -0.56% 240K
|
|
| O: 3.7%
H: 2.57%
C: 0.22%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.09%
medical therapeutics
Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 as Cancer Treatment Gains Traction - Future Market Insights, Inc.
Published: 2024-03-25 (Crawled : 15:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.08%
H: 0.15%
C: -0.44%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.06%
H: 0.96%
C: 0.26%
CAH | $108.19 2.07% 0.0% 1.5M
|
Distribution Services
|
| O: 0.02%
H: 0.73%
C: -0.02%
LNTH | $63.8 2.36% 2.3% 800K
|
Health Technology
|
| O: 0.1%
H: 1.98%
C: -0.08%
reach cancer treatment market
Blacksmith Medicines to Present at the Gordon Research Conference on New Antibacterial Discovery and Development
Published: 2024-03-19 (Crawled : 15:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.55%
H: 2.03%
C: 1.89%
conference antibacterial research
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.